Abstract | PURPOSE OF REVIEW: The purpose of this article is to review the current therapy of Addison's disease and to highlight recent developments in this field. RECENT FINDINGS: SUMMARY: Following more than 60 years with no significant innovation in the management of Addison's disease, these new approaches hold promise for improved patient health and better quality of life in the future.
|
Authors | Catherine Napier, Simon H S Pearce |
Journal | Current opinion in endocrinology, diabetes, and obesity
(Curr Opin Endocrinol Diabetes Obes)
Vol. 21
Issue 3
Pg. 147-53
(Jun 2014)
ISSN: 1752-2978 [Electronic] England |
PMID | 24755997
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Anti-Inflammatory Agents
- Glucocorticoids
- Adrenocorticotropic Hormone
- Fludrocortisone
- Hydrocortisone
|
Topics |
- Addison Disease
(drug therapy)
- Administration, Oral
- Adrenocorticotropic Hormone
(metabolism)
- Anti-Inflammatory Agents
(administration & dosage)
- Female
- Fludrocortisone
(administration & dosage)
- Glucocorticoids
(administration & dosage)
- Hormone Replacement Therapy
(methods)
- Humans
- Hydrocortisone
(administration & dosage)
- Infusions, Subcutaneous
- Male
- Patient Education as Topic
- Quality of Life
- Treatment Outcome
|